Example: Heart Attack

Clinical Trials on Hamartoma

Total 84 results

    • NCT04707209
      Recruiting
      Sirolimus for Retinal Astrocytic Hamartoma
      Conditions: Retinal Astrocytic Hamartoma
    • NCT03604055
      Completed
      Can Recurrence of Hamartomas be Prevented?
      Conditions: Airway Obstruction; Hamartoma of Lung
    • NCT03630523
      Unknown status
      Response of Immune System to Flu Vaccination in PHTS
      Conditions: PTEN Hamartoma Tumor Syndrome
    • NCT02991807
      Active, not recruiting
      RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome
      Conditions: PTEN Gene Mutation; PTEN Hamartoma Tumor Syndrome
    • NCT00971789
      Completed
      Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes
      Conditions: Cowden's Disease; Hamartoma Syndrome, Multiple
    • NCT03680924
      Completed
      Access to Resources for Patients With PTEN Hamartoma Tumor Syndrome
      Conditions: PTEN Gene Mutation
    • NCT02461446
      Recruiting
      Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
      Conditions: PTEN; ASD; Autism; Macrocephaly; PTEN Hamartoma Tumor Syndrome
    • NCT00620594
      Completed
      A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer
      Conditions: Breast Cancer; Advanced Solid Tumors; Cowden Syndrome
    • NCT04094675
      Recruiting
      Sirolimus for Cowden Syndrome With Colon Polyposis
      Conditions: PTEN Gene Mutation; PTEN Hamartoma Tumor Syndrome; PTEN Hamartoma Syndrome; Cowden Syndrome; Bannayan Syndrome; Bannayan Zonana Syndrome; Polyposis
    • NCT01247597
      Recruiting
      DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
      Conditions: Pleuropulmonary Blastoma; Cystic Nephroma; Ovarian Sertoli-Leydig Cell Tumors; Ocular Medulloepithelioma; Nasal Chondromesenchymal Hamartoma
    • NCT00600275
      Completed
      A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer
      Conditions: Solid Tumors; Breast Cancer; Cowden Syndrome
    • NCT03028246
      Recruiting
      A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects
      Conditions: Benign Centrally-Located Intracranial Tumors
    • NCT03050268
      Recruiting
      Familial Investigations of Childhood Cancer Predisposition
      Conditions: Acute Leukemia; Adenomatous Polyposis; Adrenocortical Carcinoma; AML; BAP1 Tumor Predisposition Syndrome; Carney Complex; Choroid Plexus Carcinoma; Constitutional Mismatch Repair Deficiency Syndrome; Diamond-Blackfan Anemia; DICER1 Syndrome; Dyskeratosis Congenita; Emberger Syndrome; Familial Acute Myeloid Leukemia; Familial Adenomatous Polyposis; Fanconi Anemia; Familial Cancer; Familial Wilms Tumor; Familial Neuroblastoma; GIST; Hereditary Breast and Ovarian Cancer; Hereditary Paraganglioma-Pheochromocytoma Syndrome; Hodgkin Lymphoma; Juvenile Polyposis; Li-Fraumeni Syndrome; Lynch Syndrome; MDS; Melanoma Syndrome; Multiple Endocrine Neoplasia Type 1; Multiple Endocrine Neoplasia Type 2; Neuroblastoma; Neurofibromatosis Type 1; Neurofibromatosis Type II; Nevoid Basal Cell Carcinoma Syndrome; Non Hodgkin Lymphoma; Noonan Syndrome and Other Rasopathy; Overgrowth Syndromes; Pancreatic Cancer; Peutz-Jeghers Syndrome; Pheochromocytoma/Paraganglioma; PTEN Hamartoma Tumor Syndrome; Retinoblastoma; Rhabdoid Tumor Predisposition Syndrome; Rhabdomyosarcoma; Rothmund-Thomson Syndrome; Tuberous Sclerosis; Von Hippel-Lindau Disease
    • NCT03382158
      Recruiting
      International PPB/DICER1 Registry
      Conditions: Pleuropulmonary Blastoma; Sertoli-Leydig Cell Tumor; DICER1 Syndrome; Cystic Nephroma; Wilms Tumor; Pineoblastoma; Renal Sarcoma; Nodular Hyperplasia of Thyroid; Nasal Chondromesenchymal Hamartoma; Ciliary Body Medulloepithelioma; Neuroblastoma; Pituitary Cancer; Embryonal Rhabdomyosarcoma
    • NCT03702309
      Recruiting
      Liquid Biopsy Evaluation and Repository Development at Princess Margaret
      Conditions: Cancer; Breast Cancer; Lung Cancer; Colon Cancer; Ovarian Cancer; Melanoma; Lymphoma; Leukemia; Mutation; Lynch Syndrome; Cowden Syndrome; BRCA1 Mutation; BRCA2 Mutation; Uterine Cancer; Myeloma; Kidney Cancer; Head and Neck Cancer; Meningioma
    • NCT00001404
      Completed
      Phenotype and Etiology of Pallister-Hall Syndrome
      Conditions: Malformations; Multiple Abnormalies; Polydactyly
    • NCT04316546
      Not yet recruiting
      ARQ 092 (Miransertib) in Proteus Syndrome
      Conditions: Proteus Syndrome
    • NCT03317366
      Available
      Expanded Access to Provide ARQ 092 for the Treatment of Overgrowth Diseases and/or Vascular Anomalies
      Conditions: Proteus Syndrome; PIK3CA-Related Overgrowth Spectrum (PROS); Growth Disorders
    • NCT03094832
      Active, not recruiting
      Study of Miransertib (MK-7075) in Participants With PIK3CA-related Overgrowth Spectrum and Proteus Syndrome (MOSAIC) (MK-7075-002)
      Conditions: PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome
    • NCT02594215
      Active, not recruiting
      Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome
      Conditions: Proteus Syndrome
    • NCT01369953
      Completed
      Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants
      Conditions: Coronary Artery Disease; Proteus Syndrome; Coffin - Sins Syndrome; Familial Isolated Hyperparathyroidism; Dubouitz Syndrome
    • NCT00001403
      Recruiting
      Study of Proteus Syndrome and Related Congenital Disorders
      Conditions: Proteus Syndrome; PIK3CA Related Overgrowth Spectrum
    • NCT04285346
      Recruiting
      Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B)
      Conditions: Tuberous Sclerosis
    • NCT04112537
      Active, not recruiting
      Dermatologic Patterns of Tuberous Sclerosis Patients and Somatic Mutation Relationship
      Conditions: Tuberous Sclerosis Complex
    • NCT03525834
      Completed
      Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.
      Conditions: Renal Angiomyolipoma
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations